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Abstract
Background: Disease-specific genetic information has been increasing at rapid rates as a consequence of recent
improvements and massive cost reductions in sequencing technologies. Numerous systems designed to capture
and organize this mounting sea of genetic data have emerged, but these resources differ dramatically in their
disease coverage and genetic depth. With few exceptions, researchers must manually search a variety of sites to
assemble a complete set of genetic evidence for a particular disease of interest, a process that is both time-
consuming and error-prone.
Methods: We designed a real-time aggregation tool that provides both comprehensive coverage and reliable
gene-to-disease rankings for any disease. Our tool, called Genotator, automatically integrates data from 11
externally accessible clinical genetics resources and uses these data in a straightforward formula to rank genes in
order of disease relevance. We tested the accuracy of coverage of Genotator in three separate diseases for which
there exist specialty curated databases, Autism Spectrum Disorder, Parkinson’s Disease, and Alzheimer Disease.
Genotator is freely available at http://genotator.hms.harvard.edu.
Results: Genotator demonstrated that most of the 11 selected databases contain unique information about the
genetic composition of disease, with 2514 genes found in only one of the 11 databases. These findings confirm
that the integration of these databases provides a more complete picture than would be possible from any one
database alone. Genotator successfully identified at least 75% of the top ranked genes for all three of our use
cases, including a 90% concordance with the top 40 ranked candidates for Alzheimer Disease.
Conclusions: As a meta-query engine, Genotator provides high coverage of both historical genetic research as
well as recent advances in the genetic understanding of specific diseases. As such, Genotator provides a real-time
aggregation of ranked data that remains current with the pace of research in the disease fields. Genotator’s
algorithm appropriately transforms query terms to match the input requirements of each targeted databases and
accurately resolves named synonyms to ensure full coverage of the genetic results with official nomenclature.
Genotator generates an excel-style output that is consistent across disease queries and readily importable to other
applications.
Background
The promise of personalized and genetic-based medicine
has encouraged researchers to develop new technologies to
search for genetic causes of common disease. More and
more genome data are becoming available due to these
technological advances in genotyping and increasing
numbers of genome-wide association studies (GWAS).
Concomitant with this rise in disease genomics is the rise
of publicly accessible databases to report clinical relevance
of mutations and provide rankings of genes in terms of
their roles in disease. Top among these include several
large and established resources like Online Mendelian
Inheritance in Man (OMIM) [1], The Human Gene Muta-
tion Database (HGMD) [2], and GeneCards [3] that
attempt to cover a wide range of human disease using
semi-automated approaches, as well as smaller resources
devoted to manual reports of genetic association to high
profile diseases, including SFARI Gene for Autism [4],
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any medium, provided the original work is properly cited.PDGene for Parkinson’s Disease (PD) [5], and AlzGene for
Alzheimer Disease [6]. The former tend to cover large
numbers of human diseases, but also tend to differ, some-
times dramatically, in their concepts of disease-gene asso-
ciation. The latter tend to be rich in content and reliability,
but also have a tendency to be incomplete in coverage and
lag behind the emerging research trends, at least in part
because much of their content is added manually. In addi-
tion, the number of such manually curated databases
remains restricted to priority diseases for which federal or
other funding is available. Many databases are also rarely
updated, difficult to navigate, provide information without
rankings, maintain inconsistent coverage of information
and/or lack a description of their methodology. While all of
these resources have merit, a researcher interested in the
complete set of the genetic knowledge for a disease or set
of diseases is left having to search through a variety of data-
bases to manually compile the results. A resource that auto-
mates this process by computationally integrating results
from a host of resources to provide best-of-breed genetic
knowledge would be a tremendous boon to the field.
Motivated by the need for an integrated system for
gene-disease knowledge, we built an engine called Geno-
tator that integrates a wide array of trusted databases
and provides a rich set of annotations relating genes to
disease. We designed Genotator as a fully automated
real-time aggregator of all relevant and up-to-date infor-
mation about each gene linked to a particular disease.
Every disease term queried in the Genotator returns
with a list of genes and relevant attributes and annota-
tions for each gene. In the present manuscript we
describe the Genotator algorithm and demonstrate its
functionality using three use cases, Autism Spectrum
Disorder (ASD), Parkinson’sD i s e a s e( P D ) ,a n dA l z h e i -
mer Disease (AD).
Implementation
Databases
We manually examined 33 external databases and identi-
fied 11 that had the depth and breadth appropriate for
general disease annotation (Table 1). We chose the origi-
nal 33 based on disease coverage and comprehensiveness
and their amenability to automation via screen scraping
or other methods. We also chose only those resources
that could be queried by disease to return a gene list and
associated attributes, such as supporting citations.
Algorithm
We designed an algorithm to query a given disease term
in the 11 databases described in Table 1. The code was
w r i t t e ni nJ a v aa n dP y t h o na n dd e s i g n e dt of o r mt h e
union of the lists of genes returned from a disease query
while recording whether a gene was present in or absent
from each database. We also designed the code to run on
a research cluster so that multiple requests could be run
in batch on 6 available nodes. The length a single job was
dependent on the size of the result set and on the
response times of the 11 external resources. As a second-
ary step, the algorithm queried NCBI with the list of gene
symbols to provide an enriched set of annotations includ-
ing official gene symbol, Ensembl ID, gene ID, gene
name, chromosome, location, symbol synonyms, and
aliases (Table 2). If separate entries in the results were
found to be synonyms, the algorithm collapsed the rows
into a single entry under the official NCBI name taking
the consensus of the results from all databases queried.
The final results were formatted in a single tab-delimited
text file for display/download on the Genotator website
(example of pipeline provided in Figure 1).
In addition, we included a select group of high-value
parameters to enrich the quality of the data with regards
to clinical and experimental relevance of each gene. Spe-
cifically, we included from HuGE Navigator [7] and the
Genetic Association Database [8] the manually assigned
labels “Yes Association”, “No Association”, “Unknown
Association” (where yes association indicates positive
support for a gene’sr o l ei nt h ed i s e a s ep h e n o t y p e )f o r
each gene-article pair, p-values from genome-wide asso-
ciation studies, and the Gene Prospector score of asso-
ciation [9]. All key parameters were then compiled into
an attribute vector for scoring and ranking of genes
(described in the section immediately below). Finally, to
obtain a list of publications supporting a gene-disease
pair, we queried HuGE Navigator first with the disease
of interest and then separately with the gene name (in
this case the official gene symbol) and reported the
intersecting publications in the final results.
Score
The final step of the Genotator algorithm was the
implementation of a scoring system to assign the
strength of association per gene to the disease of inter-
est. The Genotator score (GS) compiled information
from the 11 databases using the following formula.
GS
GAD GAD GPS
DB REF
YN
=
−+
++


()
/( ) /( ) 11
GADY =T o t a ln u m b e ro f“Yes” labeled associations
for the gene and disease in the Genetic Association
Database
GADN = Total number of “No” labeled associations
for the gene and disease in the Genetic Association
Database
GPS =G e n eP r o s p e c t o r ’s score of gene-disease
association
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gene appeared in
REF = Number of total references for the given gene
The constants j , g ,a n d were used to weight the
contributions of the GPS, DB, and REF parameters. We
elected to set these values at 100, 10, and 5, respectively,
as these numbers provided the best overall performance.
However, we designed the Genotator software to enable
users the ability to alter these parameters should alter-
native weighting schemes be desired. In addition, Geno-
tator reports the complete set of attributes together with
Table 1 Databases integrated within Genotator (Statistics Gathered: June 19, 2010)
Database Website Description Statistics
GeneCards [3] [17] Searchable database of human genes that provides concise genomic,
genetic and functional information
73,017 Entries, 28,656 of them with symbols
approved by the HUGO gene nomenclature
committee
Genetic
Association
Database [8]
[18] Archive of human genetic association studies of complex diseases and
disorders
2673 genes for 5636 diseases/phenotypes
HuGE Navigator
[7]
[19] Knowledge base including information on gene-disease and gene-
gene associations
9429 genes for 2215 diseases
Human Gene
Mutation
Database [2]
[20] Database established for the study of mutational mechanisms in
human genes
72414 mutations in public release
Online
Mendelian
Inheritance in
Man [1]
[21] NCBI’s compendium of human genes and genetic phenotypes 13, 158 genes for 2799 phenotypes/diseases
Your Favorite
Gene
[22] Database containing scientific descriptions and overviews of genes
and their corresponding proteins with links to the most used gene
data-banks
~ 8595 genes
UniProt [23] [24] Central database of protein sequences with accurate, consistent, rich
sequence and functional annotation
UniProtKB/Swiss-Prot Release 2010_06 of 18-
May-10 of contains 517100 sequence entries
UniProtKB/TrEMBL Release 2010_07 of 15-Jun-
2010 of contains 11109684 sequence entries
PharmGKB [25] [26] Database of primary genotype and phenotype data, annotate gene
variants and gene-drug-disease relationships
3,197 diseases, 26,216 genes
Entrez Gene [27] Searchable database of genes, from RefSeq genomes, and defined by
sequence and/or located in the NCBI Map Viewer
42644 genes
WikiGenes [28] [29] Non-profit, open access database of articles on genes, proteins and
chemical compounds
Global community
GenAtlas [30] [31] Database containing relevant information with respect to gene
mapping and genetic diseases
22466 genes/4434 phenotypes
Table 2 The characteristics included in Genotator from select resources
Database Characteristics Incorporated
Genetic Association Database List of Genes
“Yes” Association (published statement of link between gene and disease phenotype)
“No” Association (published statement of no link between gene and disease)
p-value (from genome wide association studies)
HuGE Navigator List of Genes (official gene symbols)
Gene Prospector Score [9]
List of PubMed References
Entrez Gene List of Genes (official gene symbols)
Official Full Name
Symbol Synonyms
Chromosome Number
Location on Chromosome
Gene ID
Ensembl ID
All other databases listed in Table 1 provided a list of genes only.
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the original scoring scheme or to define an alternative
strategy. We devised the GS to serve as guide for gene
prioritization that best captures the history of biomedi-
cal research findings while also ensuring adjustability of
the threshold for inclusion/exclusion of genes.
Evaluation
We elected to use three trusted, manually updated, and
disease-specific databases to provide (1) a list of vetted
candidate genes that have clear association to the dis-
ease based on published research (linkage studies,
genome-wide association studies, etc.), and (2) an inde-
pendent ranking of the strength of association between
the genes and the disease of interest against which to
compare ranked results from Genotator. The three data-
bases, SFARI Gene, PDGene, and AlzGene target Aut-
ism Spectrum Disorder (ASD), Parkinson Disease (PD),
and Alzheimer’s Disease (AD), respectively. SFARI gene
is a leading repository of genetic information for ASD
that is updated with high frequency by manual curators.
PDGene is one of the most trusted web resources for
genes associated with PD and has previously been used
to validate the Gene Prospector scoring algorithm in Yu
et al. [9]. AlzGene [6] has a similar structure to
PDGene, and is also widely regarded as an authoritative
source of information on the genes associated with AD.
T og e n e r a t eam e t r i cf o rr a n k i n gt h eg e n e sr e p o r t e db y
SFARI, we subtracted the total number of negative from
the total number of positive associations that were
directly reported in the database. PDGene and AlzGene
provided a ranking of the top gene candidates in section
of their websites called “TopGenes”. At the time of writ-
ing, PDGene listed 32 and AlzGene listed 40 top genes.
In addition, both resources assigned a label of “strong”,
“moderate”,o r“weak” to each top gene candidate based
upon amount of evidence, extent of replication and pro-
tection from bias [10]. By utilizing these resources as a
baseline for comparison, we could determine how well
the automated procedures employed by Genotator com-
pared to standards of manual annotation, both in terms
of coverage of published research as well as in terms of
prioritization of gene candidates.
Website
We designed a web resource for open access to the Gen-
otator pipeline, available at http://genotator.hms.harvard.
edu. The site has two primary components, one for initi-
ating a query through a request form, and another for
storing results under a disorder name (Figure 2). Results
are stored persistently, together with the creation date.
A user may request to update the results for a specific
Figure 1 Genotator algorithm. A user inputs a disease term into the search field of the Genotator web resource http://genotator.hms.harvard.
edu to initiate the pipeline. Genotator then simultaneously queries the databases listed in Table 1 to generate an unordered set of genes while
resolving synonyms and removing duplicate entries. The algorithm then gathers characteristics from specific databases, principally including
GAD, Gene Prospector (from HuGE Navigator), and NCBI, in order to build an attribute vector and to calculate a relevance score (scoring
algorithm detailed in the Implementation section, dark red fields are used in calculating the final Genotator score). The complete set of results,
including the Genotator score, associated gene attributes and supporting publications, are displayed directly in the website and made available
for download.
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the last creation date. The request form requires a disor-
der name, following the standard vocabulary of the Uni-
fied Medical Language System, and an active email
address. An automatic email is sent to the user when the
pipeline completes. The results are then displayed in the
“Disorders” tab and saved until updated. Each result set
can be displayed in the browser or downloaded in full as
a .txt file. The output contains a presence/absence matrix
of the databases in which the gene appears; this gives the
user the ability to select among the 11 databases and also
to rank/reorder the results using criteria other than the
Genotator score.
Results
Genotator yielded 663 genes for ASD, 1273 genes for PD,
and 2682 genes for AD (full sets of results provided as
Additional files 1, 2, and 3). Out of 4618 genes found from
all three queries, 77% were reported in GeneCards and
43% in HuGE Navigator, well above the total numbers of
genes added by other databases that each contributed less
t h a n3 1 %o ft h ed a t a( T a b l e3 ) .N e v e r t h e l e s s ,a l l
but OMIM and GenAtlas provided at least some non-
overlapping gene information. In fact, a total of 2514
genes, 54% of the total found by Genotator, were listed as
linked to the disease in only one database (Figure 3), sug-
gesting that their inclusion within the Genotator workflow
provided new, and potentially valuable information about
the genes involved in human disease.
Autism
When using “Autism” as the query term in the Genota-
tor disease search, 663 genes were returned. Six of the
top 10 genes returned were listed among the most pro-
mising autism candidates in a recent review (Table 4)
[11], demonstrating that the top ranked genes by Geno-
tator match recent advances in our understanding of
autism genetics. Using our method to rank the 197
SFARI genes, we compared the ordered lists from
SFARI and Genotator. Genotator found a total of 77%
Figure 2 Screen shot of the main components of Genotator. Genotator is freely accessible at http://genotator.hms.harvard.edu. (A) The site
consists of a splash page, (B) a disorders/diseases page that stores the complete set of results for all queries in alphabetical order, (C) and a
query page that accepts a single disease or comma separated disease list and email address for alerting users when the query completes.
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SFARI genes were included in the Genotator set, as well
as 19 out of the top 20, 29 out of the top 30, 35 out of
the top 40, and 41 out of the top 50.
Parkinson’s Disease
As in Yu et al. 2008, we used the well-known PDGene
database as a source for validation of the accuracy and
coverage of Genotator. The PDGene database provided
a relative ranking (based on HuGENet/Venice grades
[10]) that enabled us to determine the extent of overlap
with Genotator, both in terms of coverage and strength
of association to the disease. Twenty-one of the 32
PDGene “Top Results” genes were in the top 10th per-
centile of the results returned by Genotator, and in total
58% (312/540 PDGene genes) were found to be in com-
mon (Table 5). In addition, 6 of the top 10 Genotator
genes were listed among the most promising PD gene
candidates in a recent review (Table 5) [12], indicating
that Genotator appropriately prioritized leading research
in the field.
Alzheimer Disease
A saf i n a lu s ec a s e ,w ef o c u s e do nA Da n dt h ew e l l -
known AlzGene database. Similar to the PDGene data-
base, AlzGene provided a relative ranking (based on
HuGENet/Venice grades[10]) that enabled us to deter-
mine the extent of overlap with Genotator in terms of
coverage and strength of association to the disease. Of
the three disease use cases, Genotator appeared to per-
form best with Alzheimer Disease. Thirty-four of the 40
AlzGene “Top Results” genes were in the top 10th per-
centile of the results returned by Genotator, and in total
74% (486/660) of the candidate genes reported in Alz-
Gene were found by Genotator (Table 6).
Discussion
As we advance into the era of personalized medicine, our
ability to annotate the human genome with clinically
actionable information is paramount. An important step
in that annotation process is accurate characterization of
the genetic etiology of any human disease. Numerous
informatics approaches have been and are being devel-
oped to assist in this process, including methods for fil-
tering biomedical knowledge for gene-disease association
(e.g. [13], [14]), as well as full scale natural language pro-
cessing approaches [15,16], although the corpora neces-
sary for both high precision and recall remain incomplete
[16]. As these strategies have matured, an abundance of
databases have emerged to provide summaries of recent
and historical advances in human disease research. How-
ever, because these databases differ in their coverage of
genes and annotation content, it is challenging for a
researcher to develop a complete picture for a single dis-
ease or set of diseases of interest. In order to facilitate
multi-database searching and to provide a more complete
picture of advances in genetic research of human dis-
eases, we developed a software tool called “Genotator”.
Genotator generates a comprehensive set of results for
any disease by integrating gene and annotation data from
11 externally accessible and best-of-breed genetic
resources. The results from Genotator are ranked using a
scoring system that integrates bibliomic and genomic
Table 3 The percent contribution of disease candidate
genes from each of the 11 databases totaled over
autism, Parkinson’s Disease, and Alzheimer Disease
Database % Contribution
GeneCards 76.85
HuGE Navigator 43.09
WikiGenes 30.51
Genetic Association Database 11.02
UniProt 4.87
Your Favorite Gene 3.23
Human Gene Mutation Database 3.20
PharmGKB 2.88
Online Mendelian Inheritance in Man 2.27
Entrez Gene 1.52
GenAtlas 1.23
Figure 3 Percentage of unique contribution made by each of
the 11 Genotator resources. Although a sizeable percentage of
results came from GeneCards, WikiGenes, and HugeNavigator (with
each contributing well over 200 unique genes totaled across autism,
PD, and AD), all but GeneAtlas and OMIM provided at least 9
unique genes. The total number of genes found in each database
for the three diseases are listed above the graph. The percent of
unique genes was normalized for each disease.
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association for use in future thesis testing.
To test the content of Genotator and assess the effi-
cacy of its scoring system, we applied Genotator to
three separate diseases: Autism Spectrum Disorder
(ASD), Parkinson’s Disease (PD) and Alzheimer Disease
(AD), and compared our results to the three web
resources devoted to manual curation of these diseases,
SFARI gene, PDgene, and AlzGene, respectively. Geno-
tator’s results were in high agreement, with over 75% in
common with the gene lists provided by SFARI gene for
autism, nearly 60% in common with the PDGene for PD
and almost 75% in common with AlzGene for AD.
Furthermore, the rank order provided by Genotator
matched the prioritizations by these resources, especially
among the most highly 12 ranked cohort of genes, sup-
porting the notion that Genotator provides similar cov-
erage and quality to that available from manually
curated, well-funded resources that are under active
development.
In addition, we were able to demonstrate the value-add
provided through integration of the 11 different resources
used by Genotator. Nearly every database reported genes
not reported by any of the other databases, replete with suf-
ficient justification for the gene-disease link (Figure 3).
Thus, Genotator can achieve algorithmically what would
otherwise require extensive manual labor. Genotator also
provides an enriched output with features often lacking
from other disease annotation including synonym disambi-
guation, standard HGNC nomenclature, and the ability to
Table 4 Top scoring autism genes ranked on Genotator score
Gene Score Literature Support Reference AG
Classification
SLC6A4 136.7 Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive
subset of autism.
[32] Probable
NRXN1 27.2 Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental
delay, and speech delay.
[33] Promising
FMR1 22.6 Association and transmission analysis of the FMR1 IVS10 + 14C-T variant in autism [34] Probable
PTEN 19.6 Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with
germline PTEN tumour suppressor gene mutations.
[35] Probable
FRAXA* 17.9 Point mutation analysis of the FMR-1 gene in autism. [36]
FRAXE* 17.9 Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing
FRAXE.
[37]
FRAXF* 17.3 Mental impairment and attention deficit hyperactivity disorder in a family with FRAXF. [38]
CNTNAP2 15.9 Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. [39,35] Probable
UBE3A 14.5 Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. [40] Probable
CDH10 12 Common genetic variants on 5p14.1 associate with autism spectrum disorders. [41]
The table lists the title and reference of the research study supporting the gene-disease association together with the official gene symbol. We used the review
article by Abrahams and Geschwind (2008) as a source for the most promising autism gene candidates (AG classification). Starred genes are those that did not
appear in SFARI Gene. The complete results are available online as Additional file 1.
Table 5 Top 10 Parkinson’s Disease Genes ranked on Genotator score
Gene Score Literature Support Reference WRW
Mention
LRRK2 105.1 Frequency of LRRK2 mutations in early-and late-onset Parkinson disease. [42] Y
MAPT 60.8 Different MAPT haplotypes are associated with Parkinson’s disease and progressive supranuclear palsy. [43] Y
SNCA 59.8 Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for
Parkinson disease.
[44] Y
PARK2 59.6 Case-control study of the parkin gene in early-onset Parkinson disease. [45] Y
APOE 34.7 Phenotypic associations of tau and ApoE in Parkinson’s disease. [46]
GBA 21.4 Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. [47] Y
BDNF 19.5 BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s
disease.
[48]
DRD2 18.7 Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease. [49]
MAOB 17.1 Association of variations in monoamine oxidases A and B with Parkinson’s disease subgroups. [50]
PINK1 16.8 Parkin and PINK1 mutations in early-onset Parkinson’s disease: comprehensive screening in publicly
available cases and control.
[51] Y
The table lists the title and reference of the research study supporting the gene-disease association together with the official gene symbol. We used the recent
review article by Wider, Ross, and Wszolek (2010) as a source for the most promising Parkinson’s disease gene candidates (WRW Mention). A complete set of
results is available online as Additional file 2.
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ids, and scores.
As the boundaries between diseases become more
obscured, and as our definitions evolve in the wake of
new genetic information, resources that provide high
coverage of human disease are becoming increasingly
more important. While Genotator will not obviate the
need for manually curated disease-specific databases
going forward, it will enable researchers to keep pace
with the research being done on their disease of interest,
including those for which devoted websites do not cur-
rently exist.
Conclusions
Genotator is a comprehensive biomedical informatics tool
that integrates over a host of mainstream databases to pro-
vide automatic and up-to-date information on any human
disease. Based on our analysis using three well-studied dis-
orders, we confirmed that the results generated by Geno-
tator match the quality and coverage of manually curated
and disease-specific databases. This outcome, coupled
with the highly flexible and detailed output, make Genota-
tor a novel and valuable contribution to the field.
Availability and Requirements
Software Name: Genotator
Project home page: http://genotator.hms.harvard.edu
Programming Languages: Java, Python; source code
available by request
Additional material
Additional file 1: Complete Genotator results for autism. Contains
the complete set of genes identified by Genotator as linked to autism
together with the full set of attributes gathered by the Genotator
resource (Figure 1).
Additional file 2: Complete Genotator results for Parkinson’s
Disease. Contains the complete set of genes identified by Genotator as
linked to Parkinson Disease together with the full set of attributes
gathered by the Genotator resource (Figure 1).
Additional file 3: Complete Genotator results for Alzheimer Disease.
Contains the complete set of genes identified by Genotator as linked to
Alzheimer Disease together with the full set of attributes gathered by the
Genotator resource (Figure 1).
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